|
On The Fly
|
Check out this evening's… ShowHide Related Items >><< - $409.67 /
+35.805 (+9.58%) - 03/01/21
- Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates
- 03/01/21
- Lumen announces launch of Zoom Phone
- 02/03/21
- Zoom Video announces availability of Zoom Rooms innovations
- 01/26/21
- User reports indicate Zoom Video experiencing issues, says DownDetector
- 03/01/21
- TTEC Holdings raises semi-annual dividend by 7.5% to 43c per share
- 01/21/21
- TTEC Holdings partners with Schwan's Home Delivery
- 12/03/20
- TTEC Holdings declares special, one-time cash dividend of $2.14 per share
- 09/28/20
- TTEC Holdings increases semi-annual cash dividend to 40c per share
- 03/01/21
- TransMedics announces scheduling of OCS Heart FDA AdCom meeting
- 09/28/20
- FDA postpones advisory committee meeting to review TransMedics OCS Heart
- 03/01/21
- Switch drops about 7% to $16.51 after reporting mixed Q4 results
- 09/16/20
- Switch appoints Angela Archon to Board of Directors, effective November 4
- 02/25/21
- Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment
- 02/25/21
- Sarepta announces FDA approval of Amondys 45
- 02/08/21
- Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs
- 01/13/21
- Sarepta, Genevant announce collaboration for gene editing therapeutics
- 02/25/21
- Silk Road Medical publishes study on TCAR availability and MACE
- 02/04/21
- Silk Road Medical 'isolated the root cause' related to stent recall
- 01/25/21
- Silk Road Medical voluntarily recalling additional lots of Enroute system
- 01/13/21
- Silk Road Medical reports voluntarily recall of ENROUTE SDS units
- 03/01/21
- Scientific Games drops 5% to $48.00 after reporting Q4 results
- 03/01/21
- International Game, Scientific Games sign cross-licensing agreement
- 12/10/20
- Scientific Games to supply lottery games for SISAL in Morocco
- 12/01/20
- Scientific Games partners with Genius Sports Group
- 09/23/20
- SciPlay appoints Danny Moy as Chief Strategy Officer
- $420.23 /
+25.095 (+6.35%) - 03/01/21
- Roku to acquire Nielsen's video advertising business
- 02/18/21
- Roku CEO says FY21 revenue growth to fall below levels of Q1 and Q2
- 02/18/21
- Roku reports Q4 Active accounts 51.2M vs. 36.9M last year
- 01/21/21
- Cinedigm launches All3Media's streaming channel SO... REAL App on Roku
- 02/23/21
- RedHill Biopharma to expand opaganib global Phase 2/3 COVID-19 study
- 01/29/21
- RedHill Biopharma announces independent DSMB recommendation for opaganib
- 01/06/21
- RedHill Biopharma's RHB-204 granted FDA Fast Track designation for NTM disease
- 12/31/20
- RedHill Biopharma announces safety, efficacy data from Phase 2 COVID-19 study
- 01/29/21
- OraSure's OM-505 saliva collection kit included in EUA granted to Ambry
- 01/28/21
- OraSure's saliva collection device authorized by Health Canada for COVID-19 test
- 01/26/21
- Chronomics selects OraSure's OMNIgene ORAL salive collection kit
- 01/21/21
- OraSure's saliva collection kit Included in FDA authorization for exome platform
- 02/26/21
- Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan
- 02/24/21
- Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan
- 02/22/21
- House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony
- 02/22/21
- Novavax completes enrollment of PREVENT-19 Phase 3 trial
- 02/25/21
- Twitter exploring 'super follows,' users able to subscribe for exclusive content
- 02/16/21
- Elliott buys Evergy, exits eBay in Q4
- 01/12/21
- Nielsen begins tracking premium theatrical films distributed via streaming
- 02/01/21
- NIO delivers 7,225 vehicles in January, up 352.1%
- 01/10/21
- Fly Intel: Top five weekend stock stories
- 01/10/21
- Nio partners with Nvidia to develop new generation of automated driving EV
- 01/03/21
- NIO Inc. reports 7,007 vehicle deliveries in December 2020
- 03/01/21
- Point72 Asset Management reports 6.4% passive stake in Mereo BioPharma
- 12/17/20
- Ultragenyx, Mereo BioPharma announce setrusumab license agreement
- 12/15/20
- Mereo BioPharma provides update on continued listing of ADSs on Nasdaq
- 11/23/20
- Mereo BioPharma appoints Suba Krishnan as SVP, clinical development
- $84.57 /
+48.64 (+135.37%) - 03/01/21
- Morphic Holding Inc trading resumes
- 03/01/21
- Morphic Holding Inc trading halted, volatility trading pause
- 03/01/21
- Morphic Holding reports interim results from Phase 1 trial of MORF-057
- 01/05/21
- Morphic Therapeutic expands R&D collaboration with Janssen
- $1,715.90 /
+80.81 (+4.94%) - 02/16/21
- Lone Pine bought Snap and Carvana during Q4, exited PayPal
- 01/07/21
- MercadoLibre announces repurchase of $440M convertible senior notes
- 11/24/20
- Amazon Web Services selected by MercadoLibre as primary cloud provider
- 01/21/21
- Lemonade director sells 65.5K shares of common stock
- 01/14/21
- Lemonade falls -4.9%
- 01/12/21
- Lemonade falls -6.0%
- 12/31/20
- Lemonade reports over 1M active customers at end of 2020
- 02/24/21
- Inseego to sell Ctrack South Africa operations for $36.2M
- 03/01/21
- Inovio reports REVEAL 1 trial met primary, secondary endpoints
- 02/24/21
- Qiagen, Inovio expand collaboration to develop NGS companion diagnostic
- 02/23/21
- Inovio doses first patient in Phase 1B clinical trial for INO-4500
- 01/06/21
- Inovio reports positive efficacy results from Phase 2 trial of VGX-3100
- 01/21/21
- Helios Technologies to acquire BJN Technologies, terms undisclosed
- 10/12/20
- Helios Technologies to acquire Balboa Water Group for $218.5M
- 03/01/21
- FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA
- 12/22/20
- FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab
- 12/19/20
- AstraZeneca updates on U.S. regulatory review of roxadustat
- 12/18/20
- FibroGen says FDA extends review period for roxadustat NDA
- 12/07/20
- Cohu CEO Luis Muller sells over $1M in company shares
- 02/25/21
- Beyond Meat says currently in 'solid liquidity position'
- 02/25/21
- Beyond Meat says proceeding with 'aggressive investment agenda' in 2021
- 02/25/21
- Beyond Meat says seeing 'great growth' in household penetration
- 02/25/21
- Beyond Meat says 'not prepared to elaborate' on new partnerships
ASLN Aslan Pharmaceuticals - 03/01/21
- Aslan Pharmaceuticals reports 'positive' results from study of ASLAN004
- 02/18/21
- Aslan Pharmaceuticals appoints Neil Graham to board of directors
- 01/26/21
- Aslan Pharma's ASLAN003 shows potential for best-in-class DHODH inhibitor
- 10/22/20
- Aslan Pharmaceuticals initiates third dose cohort of ASLAN004
- $160.72 /
-4.985 (-3.01%) - 09/08/20
- AppFolio sells MyCase to Apax Partners fund for $193M
- 02/17/21
- Ameresco in ESA pact with Nyack Public School District for phase ll renovations
- 02/05/21
- Ameresco partners with Navy for $173M energy project at Norfolk Naval Shipyard
- 02/02/21
- Ameresco, Wells Fargo announce collaboration to develop solar generation assets
- 11/25/20
- Ameresco CEO sells 46.3K shares of common stock
- 02/25/21
- C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform
- 02/01/21
- Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative
- 12/31/20
- C3.ai falls -5.9%
- 12/30/20
- C3.ai rises 5.6%
- 02/11/21 Oppenheimer
- Opco starts DNA medicines 'disruptor' Inovio with buy, $35 price target
- 02/11/21 Oppenheimer
- Inovio initiated with an Outperform at Oppenheimer
- 02/09/21 Maxim
- Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
- 01/08/21 Benchmark
- Inovio price target lowered to $15 from $25 at Benchmark
ASLN Aslan Pharmaceuticals - 03/01/21 Piper Sandler
- Piper boosts Aslan target to $10 after positive atopic dematitis data
- 04/13/20 Piper Sandler
- Aslan interim data for ASLN004 study still expected in 2020, says Piper Sandler
- 03/18/20 Piper Sandler
- Aslan Pharmaceuticals price target lowered to $6 from $8 at Piper Sandler
- 12/17/20 Canaccord
- TTEC Holdings price target raised to $90 from $77 at Canaccord
- 10/15/20 Canaccord
- TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
- 10/15/20 Canaccord
- TTEC Holdings initiated with a Buy at Canaccord
- 08/10/20
- Fly Intel: Top five analyst downgrades
- $409.67 /
+35.805 (+9.58%) - 01/26/21 MKM Partners
- Fiverr downgraded to Sell from Neutral at MKM Partners
- 01/13/21 Stifel
- Stifel says Zoom growth with Phone reminder of 'powerful' enterprise opportunity
- 01/13/21 Morgan Stanley
- Investors have turned too negative on Zoom's persistence, says Morgan Stanley
- 12/24/20 DA Davidson
- DA Davidson likes Zoom push into email, says buy on recent selloff
- 10/12/20 Baird
- Helios Technologies upgraded to Outperform from Neutral at Baird
- 05/29/20 Morgan Stanley
- Morgan Stanley upgrades Helios to Equal Weight following underperformance
- 05/29/20 Morgan Stanley
- Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
- 03/27/20 Truist
- Helios Technologies price target lowered to $36 from $45 at SunTrust
- 02/09/21 B. Riley
- Ameresco price target raised to $72 from $50 at B. Riley Securities
- 01/26/21 Craig-Hallum
- Ameresco price target raised to $75 from $50 at Craig-Hallum
- 11/03/20 Craig-Hallum
- Ameresco price target raised to $50 from $38 at Craig-Hallum
- 11/03/20 B. Riley
- Ameresco price target raised to $50 from $48 at B. Riley Securities
- 02/24/21 Cowen
- TransMedics price target raised to $44 from $20 at Cowen
- 10/08/20
- Fly Intel: Top five analyst downgrades
- 10/08/20 JPMorgan
- TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
- 10/08/20 JPMorgan
- TransMedics downgraded to Neutral from Overweight at JPMorgan
- $420.23 /
+25.095 (+6.35%) - 02/22/21 Needham
- Roku price target raised to $550 from $400 at Needham
- 02/19/21 Truist
- Roku price target raised to $480 from $390 at Truist
- 02/19/21 JPMorgan
- Roku price target raised to $525 from $475 at JPMorgan
- 02/19/21 Oppenheimer
- Roku price target raised to $500 from $260 at Oppenheimer
- 03/01/21 Truist
- Nielsen price target raised to $26 from $20 at Truist
- 01/28/21 Citi
- Nielsen price target raised to $27 from $22 at Citi
- 11/03/20 Deutsche Bank
- Nielsen price target lowered to $18 from $22 at Deutsche Bank
- 08/25/20 Truist
- Nielsen price target lowered to $20 from $23 at Truist
- 02/01/21 H.C. Wainwright
- FibroGen initiated with a Buy at H.C. Wainwright
- 12/21/20 Mizuho
- FibroGen should be bought on PDUFA extension weakness, says Mizuho
- 10/26/20 Raymond James
- FibroGen initiated with an Underperform at Raymond James
- 10/26/20 Raymond James
- FibroGen initiated with an Underperform at Raymond James
- 01/04/21 KeyBanc
- C3.ai initiated with a Sector Weight at KeyBanc
- 01/04/21 Wedbush
- Wedbush bullish on C3.ai, initiates with an Outperform
- 01/04/21 Canaccord
- C3.ai initiated with a Hold at Canaccord
- 01/04/21 Morgan Stanley
- C3.ai initiated with an Underweight at Morgan Stanley
- 02/17/21 Cowen
- Inseego price target raised to $20 from $17 at Cowen
- 09/04/20 Stifel
- Inseego 5G opportunity highlighted in meetings with management, says Stifel
- 08/06/20
- Fly Intel: Top five analyst downgrades
- 08/06/20 Lake Street
- Inseego price target raised to $17 from $13 at Lake Street
- 01/21/21 Piper Sandler
- Lemonade price target raised to $163 from $105 at Piper Sandler
- 11/23/20 Morgan Stanley
- Root initiated with an Equal Weight at Morgan Stanley
- 11/12/20 Piper Sandler
- Lemonade price target raised to $71 from $63 at Piper Sandler
- 11/02/20 Piper Sandler
- Lemonade initiated with an Overweight at Piper Sandler
- $84.57 /
+48.64 (+135.37%) - 03/01/21 Wells Fargo
- Morphic Holding price target raised to $103 from $40 at Wells Fargo
- 02/02/21 RBC Capital
- Morphic Holding price target raised to $50 from $35 at RBC Capital
- 10/26/20 RBC Capital
- Morphic Holding initiated with an Outperform at RBC Capital
- 08/11/20 BMO Capital
- Morphic Holding price target raised to $37 from $30 at BMO Capital
- 02/18/21 Deutsche Bank
- SciPlay price target raised to $23 from $20 at Deutsche Bank
- 02/17/21 BofA
- SciPlay double-downgraded to Underperform from Buy at BofA
- 12/22/20 Morgan Stanley
- SciPlay price target raised to $16 from $15 at Morgan Stanley
- 12/16/20 JPMorgan
- SciPlay downgraded to Neutral on tough comps at JPMorgan
- 02/26/21 HSBC
- NIO price target raised to $54 from $44.70 at HSBC
- 02/09/21 Deutsche Bank
- NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
- 01/28/21 Morgan Stanley
- NIO price target raised to $80 from $33 at Morgan Stanley
- 01/22/21
- Fly Intel: Top five analyst initiations
- 02/02/21
- Truist sees Switch positioned for long-term growth, starts at Buy
- 02/02/21 Truist
- Switch initiated with a Buy at Truist
- 01/13/21 Jefferies
- Switch upgraded to Buy on earnings growth inflection at Jefferies
- 01/13/21 Jefferies
- Switch upgraded to Buy from Hold at Jefferies
- 02/23/21 B. Riley
- B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
- 02/22/21 Cantor Fitzgerald
- Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
- 02/22/21 B. Riley
- B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
- 02/18/21 B. Riley
- Novavax price target raised to $397 from $334 at B. Riley Securities
- 02/26/21 Mizuho
- Sarepta price target raised to $160 from $158 at Mizuho
- 02/25/21 Piper Sandler
- Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label'
- 02/09/21 Morgan Stanley
- Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
- 01/12/21 Citi
- Sarepta downgraded to Neutral from Buy at Citi
- 02/04/21 Piper Sandler
- Silk Road recall update 'should be received positively,' says Piper Sandler
- 01/25/21 Piper Sandler
- Silk Road Medical recall primarily manufacturing related, says Piper Sandler
- 01/13/21 Piper Sandler
- Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
- 11/11/20 Piper Sandler
- Silk Road Medical price target raised to $58 from $54 at Piper Sandler
- 12/22/20 Lake Street
- Lake Street says OraSure test news disappointing, not due to fundamental issues
- 08/21/20
- Fly Intel: Top five analyst initiations
- 08/21/20 Evercore ISI
- OraSure initiated with an Outperform at Evercore ISI
- 08/21/20 Evercore ISI
- OraSure initiated with an Outperform at Evercore ISI
- $160.72 /
-4.985 (-3.01%) - 02/25/21 DA Davidson
- AppFolio price target raised to $126 from $110 at DA Davidson
- 01/25/21 Stephens
- AppFolio initiated with an Underweight at Stephens
- 01/25/21 Stephens
- AppFolio initiated with an Underweight at Stephens
- 10/26/20 Keefe Bruyette
- AppFolio initiated with a Market Perform at Keefe Bruyette
- 02/09/21 Craig-Hallum
- Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
- 01/19/21 Jefferies
- Scientific Games price target raised to $55 from $50 at Jefferies
- 01/14/21 Truist
- Scientific Games price target raised to $60 from $45 at Truist
- 01/14/21 Craig-Hallum
- Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum
- $1,715.90 /
+80.81 (+4.94%) - 03/01/21 Credit Suisse
- MercadoLibre price target raised to $1,925 from $1,555 at Credit Suisse
- 02/11/21
- Fly Intel: Top five analyst initiations
- 02/11/21 Scotiabank
- Scotiabank starts MercadoLibre at neutral, awaits better entry point
- 02/11/21 Scotiabank
- MercadoLibre initiated with a Sector Perform at Scotiabank
- 11/12/20 Roth Capital
- RedHill Biopharma price target lowered to $12 from $16 at Roth Capital
- 09/11/20 BTIG
- RedHill Biopharma initiated with a Buy at BTIG
- 08/14/20 Roth Capital
- Roth Capital maintains Buy on RedHill after 'noisy' quarter
- 07/07/20 SMBC Nikko
- RedHill Biopharma initiated with an Outperform at SMBC Nikko
- 02/12/21 Craig-Hallum
- Cohu price target raised to $73 from $45 at Craig-Hallum
- 02/12/21 B. Riley
- Cohu price target raised to $72 from $60 at B. Riley Securities
- 02/10/21 B. Riley
- B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion
- 01/25/21 B. Riley
- Cohu price target raised to $60 from $46 at B. Riley Securities
- 03/01/21 DA Davidson
- Beyond Meat price target raised to $145 from $133 at DA Davidson
- 02/26/21 Piper Sandler
- Beyond Meat relationship with McDonald's not much changed, says Piper Sandler
- 02/26/21 UBS
- Beyond Meat price target raised to $130 from $107 at UBS
- 02/26/21 Goldman Sachs
- Beyond Meat price target raised to $112 from $105 at Goldman Sachs
- $409.67 /
+35.805 (+9.58%) - 03/01/21
- Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96
- 03/01/21
- Zoom Video sees Q1 EPS 95c-97c, consensus 72c
- 03/01/21
- Zoom Video reports Q4 EPS $1.22, consensus 79c
- 03/01/21
- Notable companies reporting after market close
- 03/01/21
- TTEC Holdings sees FY21 EPS $4.06-$4.25, consensus $2.96
- 03/01/21
- TTEC Holdings reports Q4 EPS $1.22, consensus 71c
- 11/04/20
- TTEC Holdings raises FY20 EPS view to $2.92-$3.02 from $2.37-$2.43
- 11/04/20
- TTEC Holdings reports Q3 adjusted EPS 90c, consensus 54c
- 11/04/20
- TransMedics reports Q3 EPS (19c), consensus (32c).
- 03/01/21
- Switch sees FY21 revenue $540M-$555M, consensus $588.3M
- 03/01/21
- Switch reports Q4 adjusted EPS 6c, consensus 5c
- 11/05/20
- Switch sees FY20 revenue $510M-$518M, consensus $516.47M
- 11/05/20
- Switch reports Q3 EPS 5c, consensus 4c
- 03/01/21
- Sarepta reports Q4 EPS ($1.84), consensus ($1.77)
- 03/01/21
- Sarepta reports Q4 EPS ($1.84), consensus ($1.77)
- 11/05/20
- Sarepta reports Q3 EPS ($2.50), consensus ($1.71)
- 03/01/21
- Silk Road Medical sees FY21 revenue $102M-$108M, consensus $111.52M
- 03/01/21
- Silk Road Medical reports Q4 EPS (49c), consensus (28c)
- 11/10/20
- Silk Road Medical reports Q3 EPS (31c), consensus (28c)
- 03/01/21
- Scientific Games reports Q4 EPS (95c), consensus (47c)
- 11/04/20
- Scientific Games reports Q3 EPS ($1.23), consensus (77c)
- 11/04/20
- Scientific Games reports Q3 EPS ($1.23), consensus (77c)
- 11/04/20
- Notable companies reporting after market close
- 03/01/21
- SciPlay reports Q4 EPS 18c, consensus 26c
- 11/04/20
- SciPlay reports Q3 EPS 23c, consensus 25c
- $420.23 /
+25.095 (+6.35%) - 02/18/21
- Roku sees Q1 revenue $478M-$493M, consensus $462.97M
- 02/18/21
- Roku reports Q4 EPS 49c, consensus (5c)
- 02/18/21
- Notable companies reporting after market close
- 11/05/20
- Roku reports Q3 EPS 9c, consensus (40c)
- 11/12/20
- RedHill Biopharma reports Q3 EPS (5c), consenus (16c)
- 03/01/21
- OraSure reports Q4 EPS 3c, consensus 7c
- 11/04/20
- OraSure reports Q EPS 1c, consensus (7c)
- 03/01/21
- Novavax reports Q4 EPS ($2.70), consensus ($1.49)
- 11/09/20
- Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73
- 02/25/21
- Nielsen sees FY21 adjusted EPS $1.43-$1.54, consensus $1.66
- 02/25/21
- Nielsen reports Q4 adjusted EPS 53c, consensus 46c
- 02/24/21
- Notable companies reporting before tomorrow's open
- 03/01/21
- NIO sees Q1 revenue $1.13B-$1.16B, consensus $718.49M
- 03/01/21
- NIO reports Q4 adjusted EPS (14c), consensus (7c)
- 11/17/20
- NIO Inc. sees Q4 revenue $921.8M-$947.9M, consensus $805.66M
- 11/17/20
- NIO Inc. reports Q3 adj. EPS (12c), consensus (17c)
- 09/29/20
- Mereo BioPharma reports six months EPS (GBP1.05) vs. (22p) last year
- $84.57 /
+48.64 (+135.37%) - 03/01/21
- Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41)
- 11/09/20
- Morphic Holding reports Q3 EPS 17c, consensus (48c)
- $1,715.90 /
+80.81 (+4.94%) - 03/01/21
- MercadoLibre reports Q4 EPS ($1.02), consensus 5c
- 11/04/20
- MercadoLibre reports Q3 EPS 28c, consensus 17c
- 03/01/21
- Lemonade sees FY21 revenue $114M-$117M, consensus $111.33M
- 03/01/21
- Lemonade sees Q1 revenue $21.5M-$22.5M, consensus $22.11M
- 03/01/21
- Lemonade reports Q4 EPS (60c), consensus (64c)
- 03/01/21
- Inseego reports Q4 EPS (14c), consensus 0c
- 11/05/20
- Inseego reports Q3 adjusted EPS 1c, consensus (1c)
- 03/01/21
- Inovio reports Q4 EPS (14c), consensus (22c)
- 11/09/20
- Inovio reports Q3 EPS 11c, consensus (19c)
- 03/01/21
- Helios Technologies reports Q4 EPS 60c, consensus 41c
- 11/02/20
- Helios Technologies sees FY20 revenue $485M-$495M, consensus $486.24M
- 11/02/20
- Helios Technologies reports Q3 adjusted EPS 53c, consensus 41c
- 03/01/21
- FibroGen reports Q4 EPS (64c), consensus (24c)
- 11/05/20
- FibroGen reports Q3 EPS 35c, consensus (80c)
- 02/11/21
- Cohu sees Q1 revenue $212M-$232M, consensus $207.9M
- 02/11/21
- Cohu reports Q4 non-GAAP EPS 73c, consensus 61c
- 12/01/20
- Cohu sees Q4 revenue $195M-$200M, consensus $186.26M
- 10/29/20
- Cohu sees Q4 revenue $176M-$192M, consensus $142.64M
- 02/25/21
- Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c)
- 02/25/21
- Notable companies reporting after market close
- 11/09/20
- Beyond Meat reports Q3 adj. EPS (28c), consensus 5c
- 11/09/20
- Notable companies reporting after market close
ASLN Aslan Pharmaceuticals - 11/09/20
- Aslan Pharmaceuticals reports Q3 EPS (2c), two est. (9c)
- $160.72 /
-4.985 (-3.01%) - 03/01/21
- AppFolio reports Q4 EPS (1c), consensus 7c
- 11/09/20
- AppFolio reports Q3 EPS $3.86 vs. 14c last year
- 03/01/21
- Ameresco sees FY21 EPS $1.18-$1.26, consensus $1.22
- 03/01/21
- Ameresco reports Q4 EPS 47c, consensus 29c
- 11/02/20
- Ameresco raises FY20 adj. EPS view to 94c-$1.00 from 86c-96c
- 11/02/20
- Ameresco reports Q3 adjusted EPS 38c, consensus 25c
- 03/01/21
- C3.ai reports Q3 EPS (13c), consensus (16c)
- 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
|